REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
NCT07675824
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
271
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Open Angle Glaucoma (POAG)
Ocular Hypertension (OHT)
Interventions
DRUG:
REGN22530
Sponsor
Regeneron Pharmaceuticals